IR vs XYL: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: XYL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. IR and XYL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined IR and XYL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Ingersoll Rand is a global industrial-technology company built around mission-critical air, fluid, gas, and medical technologies. It operates through two segments: Industrial Technologies and Services, which sells air compressors, vacuum and blower systems, air treatment, power tools, and lifting equipment; and Precision and Science Technologies, which makes highly engineered pumps and fluid-management systems for medical, life-science, and specialty industrial uses. The company was formed in 2020 when Gardner Denver merged with the Industrial segment of the old Ingersoll-Rand, and it sells under brands such as Ingersoll Rand, Gardner Denver, Nash, and many acquired niche names. A large share of revenue comes from aftermarket parts, consumables, and service on a big installed base, which makes results steadier than a pure equipment maker. Ingersoll Rand is headquartered in Davidson, North Carolina.

Full IR guide

Xylem was spun out of ITT in 2011 and has become the largest publicly traded pure-play water technology company, operating through four segments: Water Infrastructure (transport and treatment for utilities), Applied Water (pumps and equipment for building and industrial use), Measurement and Control Solutions (smart meters, sensors and the Sensus platform), and Water Solutions and Services (the outsourced treatment and services business built up by the 2023 Evoqua acquisition). Its customers are heavily weighted toward water and wastewater utilities plus industrial users, which gives it exposure to non-discretionary, regulation-driven spending on aging pipes, leak detection, metering and treatment.

Full XYL guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• IR drivers: IRX operating system and margins; Disciplined bolt-on M&A.
• XYL drivers: Aging infrastructure and water scarcity; Digital water and smart metering.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Ingersoll Rand's end markets are cyclical and tied to global industrial capital spending, manufacturing activity, and specific verticals like energy and semiconductors, so downturns can slow orders and short-cycle revenue. For XYL, organic growth has been flat in recent quarters even as reported revenue grew, and that concern has already cost the stock: shares are down ~24% in 2026 as of October 16 and several analysts cut price targets in October on fears of sustained top-line pressure, so even a lower multiple leaves room for disappointment if utility or industrial demand slows.

Pick IR if you believe its drivers more; XYL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the IR and XYL guides.

IR. At $78.60 on October 16, 2026, Ingersoll Rand traded near 20 times forward earnings and about 17 times EV/EBITDA, a premium to the average industrial that reflects its aftermarket mix and IRX execution but is lower than earlier in the year after the shares fell from a 52-week high near $101. Analysts expect adjusted EPS of about $3.55 for 2026 (inside the $3.45-3.57 range management set at the start of the year) and about $3.91 for 2027. Third-quarter results on October 29, 2026 carry consensus of about $0.90 a share on $2.05 billion of revenue.

XYL. Xylem still earns a premium to many industrials, but the multiple has compressed from the mid-30s in June to about 25 times trailing earnings, as the market weighs earnings beats against revenue growth of only ~1.5% in the second quarter. Analysts expect ~$5.65 of EPS for 2026 and ~$6.22 for 2027, which puts the forward multiple near 17. The October 27 report is the next test of whether organic growth reaccelerates.

Headline figures (approximate, October 2026): IR shows revenue (ttm) ~$7.9 billion, revenue growth (q2 2026, yoy) ~8.5% (Q2 revenue ~$2.05 billion), margins (ttm) Gross ~43%; operating ~17%; net ~12%, adjusted eps (q2 2026) $0.86 vs $0.83 estimate; XYL shows revenue (ttm) ~$9.1B; Q2 2026 ~$2.34B, up ~1.5% YoY, margins gross ~39%, operating ~17%, net ~11%, net income (ttm) ~$1.0B; Q2 2026 adjusted EPS ~$1.46 vs ~$1.34 expected, p/e trailing / forward ~25x / ~17x.

IR and XYL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined IR and XYL exposure against your real portfolio. It is not an investment adviser.